Non-invasive diagnosis and follow-up of benign liver tumours.


Journal

Clinics and research in hepatology and gastroenterology
ISSN: 2210-741X
Titre abrégé: Clin Res Hepatol Gastroenterol
Pays: France
ID NLM: 101553659

Informations de publication

Date de publication:
01 2022
Historique:
received: 11 07 2021
accepted: 23 07 2021
pubmed: 2 8 2021
medline: 15 4 2022
entrez: 1 8 2021
Statut: ppublish

Résumé

Hepatocellular benign liver tumours are mainly developed on normal liver and include hepatic hemangioma, focal nodular hyperplasia and hepatocellular adenoma from the most frequent to the less frequent. The diagnosis of hepatic hemangioma and of simple hepatic biliary cysts can be performed using non-invasive criteria using liver ultrasonography or contrast enhanced MRI. Most of the time the diagnosis of focal nodular hyperplasia can be achieved using contrast-enhanced ultrasonography or contrast enhanced MRI with an additional value of hepatobiliary contrast-agent in this setting. Rarely, if a doubt persists, a tumour and non-tumour liver biopsy can be required in order to establish the diagnosis. As hepatic hemangioma, simple hepatic biliary cysts and focal nodular hyperplasia are not associated with complications, they don't require any treatments or follow-up. Hepatocellular adenomas are mainly diagnosed at histology on surgical samples or liver biopsy even if some radiological features are highly suggestive of several subtypes of hepatocellular adenomas. Finally, the management of hepatocellular adenomas should be guided according to the tumour size, gender but also to the molecular subtypes.

Identifiants

pubmed: 34333196
pii: S2210-7401(21)00144-3
doi: 10.1016/j.clinre.2021.101765
pii:
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

101765

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Jean-Charles Nault (JC)

Service d'hépatologie, Hôpital Avicenne, APHP; Université Sorbonne Paris Nord, Bobigny & INSERM UMR 1138, Centre de Recherche des Cordeliers, Université de Paris France. Electronic address: jean-charles.nault@aphp.fr.

Jean-Frédéric Blanc (JF)

Service d'hépato-gastroentérologie et d'oncologie digestive, Hôpital Haut-Lévêque, CHU Bordeaux, Pessac & INSERM U1053, Université de Bordeaux, Bordeaux France.

Lucile Moga (L)

Service d'Hépatologie et Transplantation Hépatique, Hôpital Beaujon, APHP, Clichy France.

Julien Calderaro (J)

Service de département de pathologie, Hôpital Henri-Mondor, APHP, Créteil France.

Thông Dao (T)

Service d'hépato-gastro-entérologie et nutrition, CHU Caen Normandie, Caen France.

Boris Guiu (B)

Service de radiologie diagnostique et interventionnelle Saint Eloi, CHU Montpellier, Montpellier France.

Arnaud Hocquelet (A)

Service de radiodiagnostic et radiologie interventionnelle, CHUV Lausanne, Lausanne Switzerland.

Valérie Paradis (V)

Service d'anatomo-pathologie, Hôpital Beaujon, APHP, Clichy.

Ephrem Salamé (E)

Unité de Chirurgie Digestive Endocrinienne et Bariatrique, CHU Tours, Tours France.

Victor de Lédinghen (V)

Service d'hépato-gastroentérologie et d'oncologie digestive, Hôpital Haut-Lévêque, CHU Bordeaux, Pessac & INSERM U1053, Université de Bordeaux, Bordeaux France.

Marc Bourlière (M)

Service d'hépato-gastroentérologie, Hôpital Saint Joseph & INSERM UMR 1252 IRD SESSTIM Aix Marseille Université, Marseille.

Christophe Bureau (C)

Service d'hépatologie, Hôpital Rangueil, CHU Toulouse, Toulouse France.

Nathalie Ganne-Carrié (N)

Service d'hépatologie, Hôpital Avicenne, APHP; Université Sorbonne Paris Nord, Bobigny & INSERM UMR 1138, Centre de Recherche des Cordeliers, Université de Paris France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH